DiseaseConnect: A comprehensive web server for mechanism-based disease-disease connections

Nucleic Acids Research

Volumn 42, Issue W1, 2014, Pages

  Liu, Chun Chi ^a   Tseng, Yu Ting ^a   Li, Wenyuan ^b   Wu, Chia Yu ^a   Mayzus, Ilya ^c   Rzhetsky, Andrey ^c   Sun, Fengzhu ^b   Waterman, Michael ^b   Chen, Jeremy J W ^a   Chaudhary, Preet M ^d   Loscalzo, Joseph ^e   Crandall, Edward ^b,d   Zhou, Xianghong Jasmine ^b  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; BORTEZOMIB; FLUDARABINE; MELPHALAN; THALIDOMIDE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTHRITIS; ARTICLE; BLEEDING DISORDER; CLINICAL TRIAL (TOPIC); COMORBIDITY; COMPUTER PROGRAM; CROHN DISEASE; DATA MINING; DATA PROCESSING; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG THERAPY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; MEDICAL LITERATURE; MOLECULAR BIOLOGY; MULTIPLE MYELOMA; PRIORITY JOURNAL;

COMORBIDITY; DISEASE; DRUG THERAPY; GENE EXPRESSION; HUMANS; INTERNET; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; SOFTWARE;

EID: 84904793868     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku412     Document Type: Article

References (42)

1. Hidalgo,C.A., Blumm,N., Barabási,A.-L. and Christakis,N.A. (2009) A dynamic network approach for the study of human phenotypes. PLoS Comput. Biol., 5, e1000353.
2. Rzhetsky,A., Wajngurt,D., Park,N. and Zheng,T. (2007) Probing genetic overlap among complex human phenotypes. Proc. Natl Acad. Sci. U.S.A., 104, 11694-11699.
3. Van Driel,M.A., Bruggeman,J., Vriend,G., Brunner,H.G. and Leunissen,J.A.M. (2006) A text-mining analysis of the human phenome. Eur. J. Hum. Genet., 14, 535-542.
4. Goh,K.-I., Cusick,M.E., Valle,D., Childs,B., Vidal,M. and Barabási,A.-L. (2007) The human disease network. Proc. Natl Acad. Sci. U.S.A., 104, 8685-8690.
5. Lee,D.-S., Park,J., Kay,K.A., Christakis,N.A., Oltvai,Z.N. and Barabási,A.-L. (2008) The implications of human metabolic network topology for disease comorbidity. Proc. Natl Acad. Sci. U.S.A., 105, 9880-9885.
6. Linghu,B., Snitkin,E.S., Hu,Z., Xia,Y. and Delisi,C. (2009) Genome-wide prioritization of disease genes and identification of disease-disease associations from an integrated human functional linkage network. Genome Biol., 10, R91.
7. Oti,M. and Brunner,H.G. (2007) The modular nature of genetic diseases. Clin. Genet., 71, 1-11.
8. Oti,M., Huynen,M.A. and Brunner,H.G. (2008) Phenome connections. Trends Genet., 24, 103-106.
9. Loscalzo,J., Kohane,I. and Barabasi,A.-L. (2007) Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol. Syst. Biol., 3, 124.
10. Sin,D.D. and Sutherland,E.R. (2008) Obesity and the lung: 4 Obesity and asthma. Thorax, 63, 1018-1023.
11. Minotti,G., Salvatorelli,E. and Menna,P. (2010) Pharmacological foundations of cardio-oncology. J. Pharmacol. Exp. Ther., 334, 2-8.
12. Barrenas,F., Chavali,S., Holme,P., Mobini,R. and Benson,M. (2009) Network properties of complex human disease genes identified through genome-wide association studies. PLoS One, 4, e8090.
13. Rappaport,N., Nativ,N., Stelzer,G., Twik,M., Guan-Golan,Y., Stein,T.I., Bahir,I., Belinky,F., Morrey,C.P., Safran,M. et al. (2013) MalaCards: an integrated compendium for diseases and their annotation. Database (Oxford)., 2013, bat018.
14. Zitnik,M., Janjíc,V., Larminie,C., Zupan,B. and Przulj,N. (2013) Discovering disease-disease associations by fusing systems-level molecular data. Sci. Rep., 3, 3202.
15. Davis,D.A. and Chawla,N. V (2011) Exploring and exploiting disease interactions from multi-relational gene and phenotype networks. PLoS One, 6, e22670.
16. Peng,K., Xu,W., Zheng,J., Huang,K., Wang,H., Tong,J., Lin,Z., Liu,J., Cheng,W., Fu,D. et al. (2013) The Disease and Gene Annotations (DGA): an annotation resource for human disease. Nucleic Acids Res., 41, D553-560.
17. Lamb,J., Crawford,E.D., Peck,D., Modell,J.W., Blat,I.C., Wrobel,M.J., Lerner,J., Brunet,J.-P., Subramanian,A., Ross,K.N. et al. (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science, 313, 1929-1935.
18. Chiang,A.P. and Butte,A.J. (2009) Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clin. Pharmacol. Ther., 86, 507-510.
19. Sanseau,P., Agarwal,P., Barnes,M.R., Pastinen,T., Richards,J.B., Cardon,L.R. and Mooser,V. (2012) Use of genome-wide association studies for drug repositioning. Nat. Biotechnol., 30, 317-320.
20. Gottlieb,A., Stein,G.Y., Ruppin,E. and Sharan,R. (2011) PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol. Syst. Biol., 7, 496.
21. Frijters,R., van Vugt,M., Smeets,R., van Schaik,R., de Vlieg,J. and Alkema,W. (2010) Literature mining for the discovery of hidden connections between drugs, genes and diseases. PLoS Comput. Biol., 6.
22. Cheung,W.A., Ouellette,B.F.F. and Wasserman,W.W. (2013) Compensating for literature annotation bias when predicting novel drug-disease relationships through Medical Subject Heading Over-representation Profile (MeSHOP) similarity. BMC Med. Genomics, 6 Suppl 2, S3.
23. Lopes,C.T., Franz,M., Kazi,F., Donaldson,S.L.,Morris,Q. and Bader,G.D. (2010) CytoscapeWeb: an interactive web-based network browser. Bioinformatics, 26, 2347-2348.
24. Bodenreider,O. (2004) The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res., 32, D267-D270.
25. Barrett,T., Wilhite,S.E., Ledoux,P., Evangelista,C., Kim,I.F., Tomashevsky,M., Marshall,K.A., Phillippy,K.H., Sherman,P.M., Holko,M. et al. (2013) NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res., 41, D991-D995.
26. Aronson,A.R. and Lang,F.-M. (2010) An overview of MetaMap: historical perspective and recent advances. J. Am. Med. Inform. Assoc., 17, 229-236.
27. Welter,D., MacArthur,J., Morales,J., Burdett,T., Hall,P., Junkins,H., Klemm,A., Flicek,P., Manolio,T., Hindorff,L. et al. (2014) The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res., 42, D1001-D1006.
28. Knox,C., Law,V., Jewison,T., Liu,P., Ly,S., Frolkis,A., Pon,A., Banco,K., Mak,C., Neveu,V. et al. (2011) DrugBank 3.0: a comprehensive resource for "omics" research on drugs. Nucleic Acids Res., 39, D1035-D1041.
29. Rzhetsky,A., Iossifov,I., Koike,T., Krauthammer,M., Kra,P., Morris,M., Yu,H., Duboué,P.A., Weng,W., Wilbur,W.J. et al. (2004) GeneWays: a system for extracting, analyzing, visualizing, and integrating molecular pathway data. J. Biomed. Inform., 37, 43-53.
30. OMIM - Online Mendelian Inheritance in Man (http://www.omim.org/).
31. Maslov,S. and Sneppen,K. (2002) Specificity and stability in topology of protein networks. Science, 296, 910-913.
32. Hamosh,A., Scott,A.F., Amberger,J.S., Bocchini,C.A. and McKusick,V.A. (2005) Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res., 33, D514-D517.
33. Barabási,A.-L., Gulbahce,N. and Loscalzo,J. (2011) Network medicine: a network-based approach to human disease. Nat. Rev. Genet., 12, 56-68.
34. Hu,H., Yan,X., Huang,Y., Han,J. and Zhou,X.J. (2005) Mining coherent dense subgraphs across massive biological networks for functional discovery. Bioinformatics, 21(Suppl. 1), i213-221.
35. Rai,K.R., Peterson,B.L., Appelbaum,F.R., Kolitz,J., Elias,L., Shepherd,L., Hines,J., Threatte,G.A., Larson,R.A., Cheson,B.D. et al. (2000) Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.N. Engl. J. Med., 343, 1750-1757.
36. Caballero-Velázquez,T., López-Corral,L., Encinas,C., Castilla-Llorente,C., Martino,R., Rosiñol,L., Sampol,A., Caballero,D., Serrano,D., Heras,I. et al. (2013) Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients. Br. J. Haematol., 162, 474-482.
37. Daly,A., Savoie,M.L., Geddes,M., Chaudhry,A., Stewart,D., Duggan,P., Bahlis,N., Storek,J., Brown,C., Shafey,M. et al. (2012) Fludarabine, busulfan, antithymocyte globulin, and total body irradiation for pretransplantation conditioning in acute lymphoblastic leukemia: excellent outcomes in all but older patients with comorbidities. Biol. Blood Marrow Transplant., 18, 1921-1926.
38. Fetter,R.B., Shin,Y., Freeman,J.L., Averill,R.F. and Thompson,J.D. (1980) Case mix definition by diagnosis-related groups. Med. Care, 18, iii, 1-53.
39. Ri,M., Iida,S., Nakashima,T.,Miyazaki,H., Mori,F., Ito,A., Inagaki,A., Kusumoto,S., Ishida,T., Komatsu,H. et al. (2010) Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress. Leukemia, 24, 1506-1512.
40. Sinn,D.-I., Lee,S.-T., Chu,K., Jung,K.-H., Kim,E.-H., Kim,J.-M., Park,D.-K., Song,E.-C., Kim,B.-S., Yoon,S.-S. et al. (2007) Proteasomal inhibition in intracerebral hemorrhage: neuroprotective and anti-inflammatory effects of bortezomib. Neurosci. Res., 58, 12-18.
41. Franks,M.E., Macpherson,G.R. and Figg,W.D. (2004) Thalidomide. Lancet, 363, 1802-1811.
42. Peters,C.P., Eshuis,E.J., Toxopeüs,F.M., Hellemons,M.E., Jansen,J.M., D'Haens,G.R.A.M., Fockens,P., Stokkers,P.C.F., Tuynman,H.A.R.E., van Bodegraven,A.A. et al. (2014) Adalimumab for Crohn's disease: Long-term sustained benefit in a population-based cohort of 438 patients. J. Crohns. Colitis, doi:10.1016/j.crohns.2014.01.012.